SAN DIEGO – August 7, 2025 – Tandem Diabetes Care, Inc. (Nasdaq: TNDM) has announced a voluntary medical device correction for select t:slim X2 insulin pumps to address a potential speaker-related issue that can trigger an error resulting in a discontinuation of insulin delivery.
Similar Posts
Sumitomo Pharma Co., Ltd. 8/7/2025 483
Record Date: 08/7/2025
Entity Name: Sumitomo Pharma Co., Ltd.
FEI Number: 3003028650
Record Type: 483
Country: Japan
Establishment Type: Drug ManufacturerLibby Laboratories, Inc. – 708259 – 06/27/2025
CGMP/Finished Pharmaceuticals/AdulteratedUnichem Pharmaceuticals (USA) Inc. Issues Voluntary Nationwide Recall of Cyclobenzaprine Hydrochloride Tablets USP 10 mg, Due to Mislabeling
08/27/2025– East Brunswick, NJ, Unichem Pharmaceuticals (USA), Inc. is voluntarily recalling one (1) lot of Cyclobenzaprine Hydrochloride Tablets USP 10 mg, to the consumer level. The Cyclobenzaprine 10mg (90ct) label was inadvertently placed on a bottle containing MeloxicamVelocity Pharma LLC – 676434 – 07/17/2024
CGMP/Finished Pharmaceuticals/AdulteratedMiers Laboratories, Ltd – 715378 – 11/03/2025
CGMP/Finished Pharmaceuticals/AdulteratedDrug Development Tool (DDT) Qualification Programs
Information about the mission and objectives of FDA’s Drug Development Tool (DDT) qualification programs.